PhRMA Chief Warns of Serious Implications for Japan Market after 2018 Pricing Reform

PhRMA Chairman Robert A. Bradway (Chairman & CEO of Amgen) Visiting PhRMA Chairman Robert A. Bradway on April 12 sounded an alarm over the outlook of Japan’s pharma market as its 2018 pricing reform package has eroded its reputation for...read more